A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Linerixibat | CAS 1345982-69-5 - Request Quote

Picture of Linerixibat
SZ CAT No:SZ-L136001
CAS No
1345982-69-5
Mol.F.
28H38N2O7S
Mol.Wt.
546.7
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Linerixibat is chemically 3-((((3R,5R)-3-butyl-3-ethyl-7-methoxy-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[f][1,4]thiazepin-8-yl)methyl)amino)pentanedioic acid. Linerixibat is supplied with detailed characterization data compliant with regulatory guideline. Linerixibat can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Linerixibat.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1345982-69-5

Purchase 1345982-69-5

Order 1345982-69-5

Enquire 1345982-69-5

price of 1345982-69-5

1345982-69-5 Supplier

1345982-69-5 Manufacturer

1345982-69-5 Exporter

buy high quality Linerixibat

Purchase Linerixibat

Linerixibat suppliers

Linerixibat manufacturers

Linerixibat price

Order Linerixibat

Enquire Linerixibat

Linerixibat cost

Linerixibat Supplier

Linerixibat Distributor

Linerixibat for Method Validation

Linerixibat Reference Standard

Linerixibat for ANDA Filing

Linerixibat for Forced Degradation Studies

Linerixibat Identification Standards

Linerixibat for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.